Zimmer Holdings, Inc. enlarged the company’s footprint in small bones with the acquisition of Tuttlingen, Germany-based Normed Medizin-Technik GmbH.
Zimmer Buys Small Bones Company
1 min read Premium comments
Secondary
A June 4, 2013 Zimmer announcement stated, “The acquisition of Normed will strengthen Zimmer’s Extremities and Trauma product portfolios and new product development capabilities in the fast growing foot and ankle and hand and wrist segments.” No sum was given of the cost of the acquisition.
Normed was founded in 1988 and is billed as “an innovative global medical company that provides a broad range of plates, screws and specialized instruments for foot and ankle and hand and wrist surgeries.” You can view company products on their YouTube site: http://www.youtube.com/user/normedgermany?feature=results_main
Company products include: titanium osteosynthesis systems for foot and upper extremities surgery; the Haensel/Clavicula plate system and pediatric orthopedic devices.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.